NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Mediphage Bioceuticals

Mediphage Bioceuticals

Private
Toronto, OntarioHealthcare & Life Scienceshttps://www.mediphage.ca/

Last Round

Grant

Jan 6, 2026

Total Funding Raised

$3.41M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Mediphage Bioceuticals is a biotechnology company that develops a non-viral gene therapy platform called ministring DNA (msDNA) for applications in gene therapy, cell engineering, and DNA vaccines.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Government Contracts

AI Layer

Application

Keywords

ministring DNAnon-viral gene therapygene delivery platformgenetic medicinemsDNADNA vectorcell and gene therapynon-viral gene deliverytherapeutic pipelinetechnology licensingminicircle DNAbiotech partnershipsin vivo gene editingStargardt DiseaseHemophilia AmRNA manufacturingAI-driven sequence design

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Mediphage Bioceuticals Comps

Public and private peers based on sector, stage, and business model.

Mediphage Bioceuticals comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Mediphage Bioceuticals Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJan 6, 2026
SeedFeb 7, 2024
SeedDec 16, 2021
GrantJun 15, 2020
SeedJul 15, 2019
Accelerator
Apr 26, 2018

Key People

Founding team and executive leadership

Nafiseh Nafissi

Chief Technology Officer

Executive Team

Mediphage Bioceuticals Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 16, 2026

    Monthly visitors increased 75% MoM.

  • Jan 27, 2026

    Monthly visitors grew 1820% MoM, from 35 to 672.

Mediphage Bioceuticals Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Mediphage Bioceuticals Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Mediphage Bioceuticals's valuation, stock price, and market status.

Firmographic Details

HeadquartersToronto, Ontario
Employee Range6
Year Founded2016
Last FundingJan 6, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.